Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| Texto Completo: | http://hdl.handle.net/10362/120616 |
Resumo: | Publisher Copyright: Copyright © 2021 Torres T, Pereira M, Paiva Lopes MJ, Rebelo C, Pedro Andrade P, Henrique M, Oliveira H, Ferreira P, Marques Pinto G, Menezes Brandão F, Rozeira J, Filipe P, Tavares Bello R. Copyright: Copyright 2021 Elsevier B.V., All rights reserved. |
| id |
RCAP_7d271602374e7125bdf3d72e8c44cce2 |
|---|---|
| oai_identifier_str |
oai:run.unl.pt:10362/120616 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository_id_str |
|
| spelling |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemicBiological agentsCOVID-19DermatologyImmunosuppressionPsoriasisPharmacologyPublisher Copyright: Copyright © 2021 Torres T, Pereira M, Paiva Lopes MJ, Rebelo C, Pedro Andrade P, Henrique M, Oliveira H, Ferreira P, Marques Pinto G, Menezes Brandão F, Rozeira J, Filipe P, Tavares Bello R. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.Background: The COVID-19 pandemic introduced new challenges in several dimensions in healthcare services. Herein, we describe the real-life strategies and therapeutic options adopted by dermatologists regarding their patients with psoriasis being treated with or with an indication for systemic therapy during the first COVID-19 lockdown period in Portugal. Methods: The study involves a web-based survey on the clinical management of systemic therapy for psoriasis during the COVID-19 pandemic administered to Portuguese dermatologists. The survey consisted of 55 questions (4 openended questions; 51 closed-ended questions), grouped into 6 sections. Results: A total of 60 dermatologists voluntarily participated in this survey. Nearly 63% of the participants opted for suspending biologics during the COVID-19 lockdown period and 23.3% increased the time between drug administrations. Eighty percent of the participants agreed that biologics did not change the probability of acquiring COVID-19 and 58.4% believed that these drugs decreased or did not change the severity of the disease. Approximately one-third of the participants opted not to prescribe a biological agent in patients despite clinical indication over the duration of the pandemic. Nearly 25% of the participants opted for suspending traditional immunosuppressant administration. Virtual appointments were an option for 93.3% of the participants. Conclusion: The COVID-19 pandemic has significantly affected the management of patients with psoriasis being treated with or with an indication for systemic therapy. Some of the decisions made during the first lockdown period were contrary to what we know today. These decisions might have had a significant impact on patients' quality of life and on future therapeutic success. An adequate interpretation and analysis of the available data will be extremely important to an insightful adaptation of the clinical practice in future confinement or restrictive scenarios.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNTorres, TiagoPereira, MartaLopes, Maria João PaivaRebelo, ClarisseAndrade, PedroHenrique, MartinhaOliveira, HugoFerreira, PauloPinto, Gabriela MarquesBrandão, Francisco MenezesRozeira, JorgeFilipe, PauloBello, Rui Tavares2021-07-06T22:18:16Z20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/120616eng1745-1981PURE: 32315267https://doi.org/10.7573/DIC.2021-4-4info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-10T16:01:27ZPortal AgregadorONG |
| dc.title.none.fl_str_mv |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| title |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| spellingShingle |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic Torres, Tiago Biological agents COVID-19 Dermatology Immunosuppression Psoriasis Pharmacology |
| title_short |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| title_full |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| title_fullStr |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| title_full_unstemmed |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| title_sort |
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic |
| author |
Torres, Tiago |
| author_facet |
Torres, Tiago Pereira, Marta Lopes, Maria João Paiva Rebelo, Clarisse Andrade, Pedro Henrique, Martinha Oliveira, Hugo Ferreira, Paulo Pinto, Gabriela Marques Brandão, Francisco Menezes Rozeira, Jorge Filipe, Paulo Bello, Rui Tavares |
| author_role |
author |
| author2 |
Pereira, Marta Lopes, Maria João Paiva Rebelo, Clarisse Andrade, Pedro Henrique, Martinha Oliveira, Hugo Ferreira, Paulo Pinto, Gabriela Marques Brandão, Francisco Menezes Rozeira, Jorge Filipe, Paulo Bello, Rui Tavares |
| author2_role |
author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) Centro de Estudos de Doenças Crónicas (CEDOC) RUN |
| dc.contributor.author.fl_str_mv |
Torres, Tiago Pereira, Marta Lopes, Maria João Paiva Rebelo, Clarisse Andrade, Pedro Henrique, Martinha Oliveira, Hugo Ferreira, Paulo Pinto, Gabriela Marques Brandão, Francisco Menezes Rozeira, Jorge Filipe, Paulo Bello, Rui Tavares |
| dc.subject.por.fl_str_mv |
Biological agents COVID-19 Dermatology Immunosuppression Psoriasis Pharmacology |
| topic |
Biological agents COVID-19 Dermatology Immunosuppression Psoriasis Pharmacology |
| description |
Publisher Copyright: Copyright © 2021 Torres T, Pereira M, Paiva Lopes MJ, Rebelo C, Pedro Andrade P, Henrique M, Oliveira H, Ferreira P, Marques Pinto G, Menezes Brandão F, Rozeira J, Filipe P, Tavares Bello R. Copyright: Copyright 2021 Elsevier B.V., All rights reserved. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-07-06T22:18:16Z 2021 2021-01-01T00:00:00Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/120616 |
| url |
http://hdl.handle.net/10362/120616 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
1745-1981 PURE: 32315267 https://doi.org/10.7573/DIC.2021-4-4 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
| instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1777303040085196800 |